(WASHINGTON)—The American Society of Hematology (ASH) today announced the names of six exceptional fellows selected to receive a 2013 Research Training Award for Fellows (RTAF) grant. This award helps fellows in hematology, hematology/oncology, or other hematology-related training programs to pursue a career in academic hematology by providing protected time to conduct research during their fellowship training.
With the goals of promoting mentorship and fostering a new generation of clinical, basic, and translational researchers in hematology, this program provides one-year, $50,000 grants to trainees who may one day make important discoveries to advance the treatment of blood disorders. Grant funding is also intended to provide bridge funds for trainees who need more time to generate sufficient expertise to be competitive when applying for K award or other similar career development funding. This year, ASH RTAF grants will be awarded to two different groups of fellows: junior investigators (second- and third-year fellows) and senior investigators (fourth- and fifth-year fellows).
“After a rigorous interview process, we have selected some of the most promising physician-scientists in the field of hematology to receive this important award,” said ASH President Janis L. Abkowitz, MD, of the University of Washington. “It is our hope that this award will enable these trainees to continue on their paths toward careers in academic hematology, and we look forward to seeing the results of their research efforts over the next year and beyond.”
The 2013 ASH Research Training Award for Fellows recipients and their research topics are as follows:
- Ming Lim, MBBChir, University of North Carolina, Chapel Hill, NC
Contribution of Erythrocytes to Thrombin Generation in Sickle Cell Disease
- Anthony Sung, MD, Duke University Hospital, Durham, NC
Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplantation
- Srinivas Tantravahi, MBBS, MRCP, Huntsman Cancer Institute, Salt Lake City, UT
Study of Mechanisms of Ponatinib Resistance
- Nicholas Vitazna, MD, New York University, New York, NY
Therapeutic Targeting of the Cyclin D3:Cdk4/6 Complex in B-Cell Leukemia
- Christopher Benton, MD, MD Anderson Cancer Center, Houston, TX
Hemangioblast-Like Cells as Stem Cells in Acute Leukemia
- Taly Glaubach, MD, Ann & Robert H. Lurie Children’s Hospital, Chicago, IL
Truncated GCSFR – Mutant RUNX1: An Axis of Evil in Secondary MDS/AML
To arrange an interview with an RTAF recipient, please contact Kaitlin Bressler at 202-552-4925 or email@example.com.
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
back to top